Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Patients in the intervention group receive 20,30 cc lactulose daily fo 3 months . Intervention 2: patients in control group receive their routine diabetes treatment without lactulose.
Treatment - Drugs
Treatment - Other
Patients in the intervention group receive 20,30 cc lactulose daily fo 3 months .
patients in control group receive their routine diabetes treatment without lactulose
Sponsors
Research deputy of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: type II diabetes; age between 30 to 70 years; HbA1c 7 to 9. Exclusion criteria: antibiotic use; presence of acute and chronic gastrointestinal diseases leading to intestinal dysfunction; HbA1c below 7 or above 9%; need to change medication or diet during the study; use of medications affecting bowel function such as drugs for peptic ulcers, probiotics, laxatives; no history of surgery on gastrointestinal tract and liver; the absence of other systemic diseases affecting the gastrointestinal tract such as uncontrolled hypothyroidism, renal failure, liver disease and advanced heart failure; lack of consent to participate in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose levels. Timepoint: Baseline and three months after starting the study. Method of measurement: Paraclinical.;Hemoglobin A1C. Timepoint: Baseline and three months after starting the study. Method of measurement: Paraclinical.;Stool probiotic bactria count. Timepoint: Baseline and three months after starting the study. Method of measurement: Culture and colony count. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Akbar Asgharzadeh
Tabriz University of Medical Sciences
Outcome results
None listed